4//SEC Filing
Geffken Daniel E. 4
Accession 0000899243-21-039940
CIK 0001870404other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 7:35 PM ET
Size
6.2 KB
Accession
0000899243-21-039940
Insider Transaction Report
Form 4
Geffken Daniel E.
Chief Financial Officer
Transactions
- Other
Class B Common Stock
2021-10-08+30,000→ 30,000 total(indirect: By LLC)→ Class A Common Stock (30,000 underlying)
Footnotes (3)
- [F1]The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date.
- [F2]Allocated to the reporting person as a member of Phoenix Biotech Sponsor, LLC.
- [F3]The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for any other purpose.
Documents
Issuer
PHOENIX BIOTECH ACQUISITION CORP.
CIK 0001870404
Entity typeother
Related Parties
1- filerCIK 0001314756
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 7:35 PM ET
- Size
- 6.2 KB